top of page

Partners

Harness ancestral RNA to elevate your discoveries to the next level

Diagnostics Companies

Generate new revenue streams with a ​view to developing this RUO test into an IVD.

​

The precedent is set: Genomic tests are getting adopted and reimbursed by payors.

Laboratories

Optimize the utilization of your NGS sequencers while generating revenue. Our product fits seamlessly into current lab workflows, no new hardware required – the FBB Test works on standard NGS sequencers.

Image by Porter Raab

Universities and Institutes

Expand the frontiers of neurologic disease research – uncover the full RNA ecosystem behind lifestyle factors and health.

How we like to build partnerships

1

Align interests and expectations

2

Run a training study with unblinded samples 

3

Run a validation study with blinded samples 

4

Submit results for peer-reviewed publication, then commercialize

Get early access to our novel technology

Contact us to validate our blood test in your preferred environment 

bottom of page